[1] CAPLAN L R. Intracranial branch atheromatous

disease：a neglected，understudied，and underused

concept[J]. Neurology，1989，39（9）：1246-1250.

[2] MEN X J，LI J J，ZHANG B J，et al. Homocysteine

and C-reactive protein associated with progression

and prognosis of intracranial branch atheromatous

disease[J/OL]. PLoS One，2013，8（9）：

e73030[2021-01-10]. https：//doi.org/10.1371/journal.

pone.0073030.

[3] MEN X J，WU A M，ZHANG B J，et al.

Leukoaraiosis and NIHSS score help to differentiate

subtypes of intracranial branch atheromatous disease

in Southern Han Chinese patients with stroke[J].

Neurol Sci，2013，34（10）：1727-1733.

[4] YAMAMOTO Y，OHARA T，HAMANAKA

M，et al. Characteristics of intracranial branch

atheromatous disease and its association with

progressive motor deficits[J]. J Neurol Sci，2011，304

（1/2）：78-82.

[5] XU W H，LI M L，GAO S，et al. Plaque distribution

of stenotic middle cerebral artery and its clinical

relevance[J]. Stroke，2011，42（10）：2957-2959.

[6] FISHER C M，CAPLAN L R. Basilar artery branch

occlusion：a case of pontine infarction[J/OL].

Neurology，1971，21：900-905[2021-01-10].

https：//doi.org/10.1212/WNL.21.9.900.

[7] FISHER C M. Bilateral occlusion of basilar artery

branches[J]. J Neurol Neurosurg Psychiatry，1977，40

（12）：1182-1189.

[8] TATSUMI S，YAMAMOTO T. An autopsied case of

an apparent pontine branch atheromatous disease[J].

Eur Neurol，2010，63（3）：184-185.

[9] DECAVEL P，VUILLIER F，MOULIN T.

Lenticulostriate infarction[J/OL]. Front Neurol

Neurosci，2012，30：115-119[2021-01-10].

https：//doi.org/10.1159/000333606.

[10] KATAOKA S，HORI A，SHIRAKAWA T，et

al. Paramedian pontine infarction. Neurological/

topographical correlation[J]. Stroke，1997，28（4）：

809-815.

进展的机制及治疗仍处于研究阶段。建议未来

开展WB-VWI可视化、多模态技术研发，以推

动WB-VWI对其他穿支动脉的显示；开展多中

心、大规模的临床治疗实验，以改善BAD患者

预后。随着科学技术的不断进步，相信能不断

地更新和改写BAD的诊断标准和治疗指南。

[11] DONNAN G A，O'MALLEY H M，QUANG L，et

al. The capsular warning syndrome：pathogenesis

and clinical features[J]. Neurology，1993，43（5）：

957-962.

[12] SAPOSNIK G，NOEL DE TILLY L，CAPLAN L R.

Pontine warning syndrome[J]. Arch Neurol，2008，65

（10）：1375-1377.

[13] PETRONE L，NANNONI S，DEL BENE A，et

al. Branch atheromatous disease：a clinically

meaningful，yet unproven concept[J]. Cerebrovasc

Dis，2016，41（1-2）：87-95.

[14] LI H，DAI Y，WU H，et al. Predictors of early

neurologic deterioration in acute pontine

infarction[J]. Stroke，2020，51（2）：637-640.

[15] YOON Y，LEE D H，KANG D W，et al. Single

subcortical infarction and atherosclerotic plaques in

the middle cerebral artery：high-resolution magnetic

resonance imaging findings[J]. Stroke，2013，44（9）：

2462-2467.

[16] LIAO S Y，DENG Z Z，WANG Y G，et al. Different

mechanisms of two subtypes of perforating artery

infarct in the middle cerebral artery territory：a

high-resolution magnetic resonance imaging study[J/

OL]. Front Neurol，2018，9：657[2021-01-10].

https：//doi.org/10.3389/fneur.2018.00657.

[17] ADACHI T，TAKAGI M. The clinical differences

between lacunar infarction and branch atheromatous

disease[J]. Nihon Rinsho，2006，64（Suppl 8）：155-

159.

[18] WU F，ZHANG Q，DONG K，et al. Whole-brain

magnetic resonance imaging of plaque burden and

lenticulostriate arteries in patients with different

types of stroke[J/OL]. Ther Adv Neurol Disord，2019，

12：1756286419833295[2021-01-10]. https：//doi.

org/10.1177/1756286419833295.

[19] JIANG S，YAN Y，YANG T，et al. Plaque

distribution correlates with morphology of

lenticulostriate arteries in single subcortical

infarctions[J]. Stroke，2020，51（9）：2801-2809.

[20] 中华医学会神经病学分会，中华医学会神经病学分

会脑血管病学组. 中国急性缺血性脑卒中诊治指南

2018[J]. 中华神经科杂志，2018，51（9）：666-682.

[21] HE L Y，XU R H，WANG J，et al. Capsular warning

syndrome：clinical analysis and treatment[J]. BMC

Neurol，2019，19（1）：285.

[22] FUSEYA Y，KAWAMURA M，MATSUDA E，et

al. rt-PA with antithrombotic therapies in a case with

capsular warning syndrome[J]. Intern Med，2017，56

（4）：441-444.

[23] LI W，WU Y，LI X S，et al. Intravenous tirofiban

therapy for patients with capsular warning syndrome[J]. Stroke Vasc Neurol，2019，4（1）：22-

27.

[24] KAMO H，MIYAMOTO N，OTANI H，et al. The

importance of combined antithrombotic treatment for

capsular warning syndrome[J]. J Stroke Cerebrovasc

Dis，2018，27（11）：3095-3099.

[25] YAMAMOTO Y，NAGAKANE Y，MAKINO M，

et al. Aggressive antiplatelet treatment for acute

branch atheromatous disease type infarcts：a 12-year

prospective study[J/OL]. Int J Stroke，2014，9（3）：

E8[2021-01-10]. https：//doi.org/10.1111/ijs.12200.

[26] WANG Y J，WANG Y L，ZHAO X Q，et al.

Clopidogrel with aspirin in acute minor stroke or

transient ischemic attack[J]. N Engl J Med，2013，

369（1）：11-19.

[27] JING J，MENG X，ZHAO X Q，et al. Dual

antiplatelet therapy in transient ischemic attack

and minor stroke with different infarction patterns：

subgroup analysis of the chance randomized clinical

trial[J]. JAMA Neurol，2018，75（6）：711-719.

[28] COULL A J，LOVETT J K，ROTHWELL P M，et

al. Population based study of early risk of stroke

after transient ischaemic attack or minor stroke：

implications for public education and organisation of

services[J]. BMJ，2004，328（7435）：326.

[29] DEGUCHI I，HAYASHI T，KATO Y，et al.

Treatment outcomes of tissue plasminogen activator

infusion for branch atheromatous disease[J/OL].

J Stroke Cerebrovasc Dis，2013，22（7）：e168-

172[2021-01-10]. https：//doi.org/10.1016/j.jstrokecere

brovasdis.2012.10.012.

[30] KIMURA T，TUCKER A，SUGIMURA T，et al.

Ultra-early combination antiplatelet therapy with

cilostazol for the prevention of branch atheromatous

disease：a multicenter prospective study[J].

Cerebrovasc Dis Extra，2016，6（3）：84-95.

[31] NISHI R，MANO T，KOBAYASHI Y，et al.

Argatroban，aspirin，and clopidogrel combination

therapy for acute penetrating artery infarction：a

pilot study[J]. Brain Nerve，2016，68（2）：181-189.